Arca
Skip to content
Tools
Tools

M: Matrix protein 2

Protein in Influenza A virus that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 1
  • In phases 1 to 3: 1
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on M, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1
  • Other 1

Approved1

  • Amantadine

Phase 30

    Phase 21

    • TCN-032

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      AmantadineApprovedEndo InternationalSmall moleculeInhibitorMatrix protein 2 inhibitor39
      TCN-032Phase 2Theraclone Sciences, Inc.OtherInhibitorMatrix protein 2 inhibitor0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
      Evaluation of the Effect of Amantadine in the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer PatientsAmantadinePhase 2Not yet recruitingAl-Azhar UniversityOct 22, 2026
      Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury (MEND)AmantadinePhase 2Not yet recruitingNova Scotia Health AuthorityOct 9, 2026
      Synaptic Mechanisms of Continuous Theta Burst Stimulation in DepressionAmantadineEarly phase 1RecruitingMclean HospitalMay 1, 2026
      Escalating Doses of Memantine in Down Syndrome (MEDS-123)AmantadinePhase 1Not yet recruitingUniversity Hospitals Cleveland Medical CenterApr 15, 2026
      Neuroprotection of Memantine and RosuvastatinAmantadinePhase 2 / Phase 3Not yet recruitingTanta UniversityMar 31, 2026
      Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the BrainAmantadinePhase 2RecruitingThe University of Texas Health Science Center at San AntonioMar 13, 2026
      Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain SyndromeAmantadineNot applicableRecruitingCairo UniversityFeb 19, 2026
      Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type DementiaAmantadinePhase 3RecruitingBigespas LTDNov 26, 2025

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1932894, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.